Evidence mapPaperPMID 34572095Full record

ArticleCells2021

Effects of Fasting and Feeding on Transcriptional and Posttranscriptional Regulation of Insulin-Degrading Enzyme in Mice.

Carlos M González-Casimiro, Patricia Cámara-Torres, Beatriz Merino, Sergio Diez-Hermano, Tamara Postigo-Casado, Malcolm A Leissring, Irene Cózar-Castellano, Germán Perdomo

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Carlos M González-CasimiroUnidad de Excelencia Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, 47003 Valladolid, Spain.ORCID 0000-0003-1640-7457
Patricia Cámara-TorresUnidad de Excelencia Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, 47003 Valladolid, Spain.
Beatriz MerinoUnidad de Excelencia Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, 47003 Valladolid, Spain.ORCID 0000-0002-4761-3977
Sergio Diez-HermanoInstitute for Research in Sustainable Forest Management (iuFOR), University of Valladolid, 34004 Palencia, Spain.ORCID 0000-0003-3830-7297
Tamara Postigo-CasadoUnidad de Excelencia Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, 47003 Valladolid, Spain.
Malcolm A LeissringInstitute for Memory Impairments and Neurological Disorders, University of California, Irvine (UCI MIND), Irvine, CA 92697-4545, USA.ORCID 0000-0001-7185-4255
Irene Cózar-CastellanoUnidad de Excelencia Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, 47003 Valladolid, Spain.ORCID 0000-0002-6065-5362
Germán PerdomoUnidad de Excelencia Instituto de Biología y Genética Molecular, University of Valladolid-CSIC, 47003 Valladolid, Spain.ORCID 0000-0002-2301-0012
Universidad de Valladolid · ESUniversity of California, Irvine · US

Funding

Temporal and spatial aspects of amyloidogenesis in sporadic Alzheimer diseaseR01AG066928 · UNIVERSITY OF CALIFORNIA-IRVINE · 2025 to 2025
$542k
European Foundation for the Study of Diabetes European Foundation for the Study of DiabetesEuropean Foundation for the Study of Diabetes European Foundation for the Study of Diabetes Rising Star Fellowship Programme supported by EFSD-Novo NordiskJunta de Castilla y León ORDER EDU/574/2018Junta de Castilla y León Programa Estratégico Instituto de Biología y Genética Molecular (IBGM), Escalera de Excelencia, Junta de Castilla y León (Ref. CLU-2019-02)"la Caixa" Foundation LCF/PR/PR18/51130007Ministerio de Ciencia e Innovación PID2019-110496RB-C21Ministerio de Ciencia e Innovación PID2019-110496RB-C22Ministerio de Economía, Industria y Competitividad, Gobierno de España SAF2016-77871-C2-1-RMinisterio de Economía, Industria y Competitividad, Gobierno de España SAF2016-77871-C2-2-RNIA NIH HHS R01 AG066928NIGMS NIH HHS R01 GM115617NIH HHS GM115617Sociedad Española de Diabetes Young Basic Researchers grant
6 · The paper itself

Abstract

Insulin-degrading enzyme (IDE) is a highly conserved and ubiquitously expressed Zn

Indexed as

FastingFeeding BehaviorGene Expression RegulationAnimalsDiet, High-FatGlucoseInsulinInsulin ResistanceInsulysinKidneyLiverMaleMiceMice, Inbred C57BLMuscle, SkeletalOrgan SpecificityGlucoseInsulinInsulysinfastinginsulin-degrading enzymeinsulin resistancelactatelivermetabolic adaptationsmetabolic flexibilitynutritional staterefeeding

Identifiers

PMID34572095
PMCPMC8467815
OpenAlexW3200046301

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.